Arrythmia

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
1 program
CareLinKN/A1 trial
Active Trials
NCT02401659Completed187Est. Oct 2017
Abbott
AbbottABBOTT PARK, IL
1 program
LV pacing siteN/A1 trial
Active Trials
NCT02057588Completed16Est. Jun 2016
P
PhilipsNetherlands - Amsterdam
1 program
ePatch ® Extended Wear HolterN/A1 trial
Active Trials
NCT06310707Terminated55Est. Jul 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsePatch ® Extended Wear Holter
Rhythm PharmaceuticalsCareLinK
AbbottLV pacing site

Clinical Trials (3)

Total enrollment: 258 patients across 3 trials

NCT06310707PhilipsePatch ® Extended Wear Holter

Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter

Start: Nov 2023Est. completion: Jul 202555 patients
N/ATerminated
NCT02401659Rhythm PharmaceuticalsCareLinK

Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems

Start: May 2014Est. completion: Oct 2017187 patients
N/ACompleted
NCT02057588AbbottLV pacing site

Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electrograms

Start: Feb 2014Est. completion: Jun 201616 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space